Worked with C-suite and an accounting firm to conduct an economic analysis, structure, and implement intercompany payments and agreements in preparation for an IPO of an innovative biotech incubator. The analysis included valuation of a unique biotech development and production facility, R&D, engineering and management services.
CRA strengthens its Transfer Pricing Practice
“We are excited to welcome Arin to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “He has more than three decades of...